Early-stage venture fund Inflexor Ventures expects to announce the first close of its $150 million (Rs 1,250 crore) Fund III by the end of ...

Insecticides India and BioPrime joined forces. They launched Relieve in India. Relieve is a seaweed and plant-based product. It boosts crop...

Pratip Mazumdar, Partner of Inflexor Ventures said that a small part of this fund will be used to acquire the entire investment portfolio o...

This week, startups, across seed, early and late-stage rounds, raised funds through 21 deals, compared to 29 deals in the year-ago period, ...

Reliance Retail is the latest entrant in the quick commerce market, taking on the likes of Blinkit, Instamart and Zepto.

The funds will be used to advance research in crop protection, with a focus on co-developing new biofungicides and bioinsecticides. Founded...

Launched in 2012, FIA Global has 35,000 outlets that function as mini bank branches. Equipped with a laptop, biometric device and printer, ...

Apple unveiled its iPhone 15 series and Watch Series 9 during its ‘Wonderlust’ event Tuesday. This and more in today’s ETtech Top 5.

Genpact is applying an ‘output robustness test’ to ensure its AI-generated output complies with fairness and legal frameworks. Wipro has ad...

Temasek-backed Vertex Ventures has raised $541 million to mark the final close of its Fund V, which will also focus on investing in women-l...

D-Day is here! In a virtual meet today, the jury of the Economic Time Startup Awards 2023 will reveal the brightest stars in India’s startu...

ETSA this year comes at a time when the technology industry faces multiple headwinds. The volatility in valuations of publicly listed tech ...

As India gears up to host the G20 Summit from Friday, cryptocurrency is expected to be an important topic of discussion at the high table, ...

After revealing the eleven-member, high-powered jury for The Economic Times Startup Awards (ETSA) 2023 and the nominees for Bootstrap Champ...

With this category, we intend to recognise the startup that best embodies the ‘double bottomline’ model, one that combines profits with the...

The company aims to utilise the funds for their SNIPR Biologicals registrations, advancing the discovery platform, building a strong IP por...